Filing Details
- Accession Number:
- 0001209191-13-053577
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2013-11-21 17:25:45
- Reporting Period:
- 2013-10-30
- Filing Date:
- 2013-11-21
- Accepted Time:
- 2013-11-21 17:25:45
- Original Submission Date:
- 2013-10-31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1330401 | Jason Hannon | 7475 Lusk Blvd San Diego CA 92121 | Evp, Gen. Counsel & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-10-30 | 1,334 | $28.07 | 18,657 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-10-30 | 1,000 | $30.00 | 17,657 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-10-30 | 15,027 | $18.31 | 32,684 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-10-30 | 15,027 | $30.00 | 17,657 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right-to-Buy) | Disposition | 2013-10-30 | 15,027 | $0.00 | 15,027 | $18.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-01-03 | 2016-01-03 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on August 22, 2013, which is intended to comply with Rule 10b5-1.
- The shares sold were acquired contemporaneously upon the cashless exercise of a stock option at an exercise price of $18.31 per share.
Billionaire Hedge Funds
